/R E P E A T -- Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study/ Finanzen, 26 Jan 2021 Develops Microbiome Diagnostic Index VANCOUVER, BC, Jan. 26, 2021 /CNW/ - Nova Mentis Life Science Corp.